Trial intelligence / Profile preview

Nevirapine Influence on Atazanavir PK in HIV

NCT00355719Phase 4Completed

Sponsor
Hospital Universitari Germans Trias i Pujol
Start
Jan 2007
Primary completion
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of nevirapine in human immunodeficiency virus infection (HIV), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Atazanavir plasma concentration at Week 4. Started Jan 2007; status: completed.

02

Drugs

nevirapine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00355719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00355719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call